Aankondiging • Feb 20
Mobiis Co., Ltd., Annual General Meeting, Mar 20, 2026 Mobiis Co., Ltd., Annual General Meeting, Mar 20, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 253, pangyo-ro, bundang-gu, gyeonggi-do, seongnam South Korea New Risk • Jan 19
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2024 fiscal period end). Share price has been highly volatile over the past 3 months (13% average weekly change). High level of non-cash earnings (36% accrual ratio). New Risk • Nov 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2024 fiscal period end). High level of non-cash earnings (36% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (₩92.5b market cap, or US$62.6m). New Risk • May 01
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended March 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2024 fiscal period end). High level of non-cash earnings (36% accrual ratio). Minor Risk Market cap is less than US$100m (₩77.0b market cap, or US$53.6m). Aankondiging • Feb 26
Mobiis Co., Ltd., Annual General Meeting, Mar 26, 2025 Mobiis Co., Ltd., Annual General Meeting, Mar 26, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 253, pangyo-ro, bundang-gu, gyeonggi-do, seongnam South Korea New Risk • Nov 16
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). High level of non-cash earnings (36% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Market cap is less than US$100m (₩91.7b market cap, or US$65.7m). Aankondiging • May 21
Hyundai Bioscience Co., Ltd. (KOSDAQ:A048410), CnPharm Co., Ltd. and Yeonjin Kim completed the acquisition of 34.91% stake in ADM Korea Inc. (KOSDAQ:A187660) from Mobiis Co., Ltd. (KOSDAQ:A250060). Hyundai Bioscience Co., Ltd. (KOSDAQ:A048410), CnPharm Co., Ltd. and Yeonjin Kim agreed to acquire 34.91% stake in ADM Korea Inc. (KOSDAQ:A187660) from Mobiis Co., Ltd. (KOSDAQ:A250060) for KRW 31 billion on March 11, 2024. As of May 16, 2024, the agreement was revised and under the revised terms Hyundai Bioscience will now acquire 30.33% stake, CnPharm will acquire 2.89% stake and Yeonjin Kim will acquire 1.69% stake in ADM Korea. Transaction is expected to May 20, 2024.
Hyundai Bioscience Co., Ltd. (KOSDAQ:A048410), CnPharm Co., Ltd. and Yeonjin Kim completed the acquisition of 34.91% stake in ADM Korea Inc. (KOSDAQ:A187660) from Mobiis Co., Ltd. (KOSDAQ:A250060) on May 20, 2024. New Risk • Feb 23
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 41% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (2.3% increase in shares outstanding). Aankondiging • May 04
Mobiis Co., Ltd. announced that it expects to receive KRW 11 billion in funding from HB Investment, Inc., SK Securities Co., Ltd. Mobiis Co., Ltd. (KOSDAQ:A250060) announced a private placement of series 3 unregistered coupon nonguaranteed private convertible bond for a gross proceeds of KRW 11,000,000,000 on May 3, 2021. The transaction will include participation from SK Securities Co., Ltd. (KOSE:A001510) for KRW 10,000,000,000, returning investor HB Investment, Inc., through its fund HB-KIS 2019 Fund for KRW 1,000,000,000. The bonds will mature on May 6, 2026. The bonds will be 100% converted into 3,529,034 common shares at a fixed conversion price of KRW 3,117 per share for an equity stake of 10.16%. The conversion period is from May 6, 2022 to April 6, 2026. The subscription and payment date of the transaction is May 6, 2021. The securities issued in the transaction are subject to a lock up period of one year. The transaction has been approved by the board of directors of the company. Is New 90 Day High Low • Feb 05
New 90-day high: ₩2,830 The company is up 11% from its price of ₩2,560 on 06 November 2020. The South Korean market is up 26% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 40% over the same period. Aankondiging • Nov 25
Mobiis Co., Ltd. announced that it expects to receive KRW 3.104 billion in funding from Mirae Asset Daewoo Co., Ltd., Shinhan Financial Investment Co., Ltd., Korea Investment & Securities Co., Ltd. Mobiis Co., Ltd. (KOSDAQ:A250060) announced a private placement of series 2 non-guaranteed private equity exchange bonds for gross proceeds of KRW 3,104,000,000 on November 23, 2020. The transaction will include participation from Mirae Asset Daewoo Co., Ltd. (KOSE:A006800), Shinhan Financial Investment Co., Ltd., Korea Investment & Securities Co., Ltd. for KRW 1,104,000,000, KRW 1,000,000,000 and KRW 1,000,000,000 respectively. The bonds issued are zero coupon bonds and will mature on November 25, 2023. The bonds to be issued are 100% convertible into 500,000 shares at a price of KRW 6,208 for 5.2% equity during the period between December 02, 2020 to October 25, 2023. The subscription date and payment date is November 25, 2020. The security to be issued in the transaction will be subject to hold period of one year. The transaction has been approved by the board of directors of the company.